Not surprisingly, Novo Nordisk, which makes Ozempic and Wegovy, and Eli Lilly, which makes Mounjaro and Zepbound, do not condone the copies of their drugs
Semaglutide GLP-1 injections have also been shown to lower the risk of a stroke, heart attack, heart or blood vessel disease, or death in patients that are obese or more at risk for these conditions, and those with type 2 diabetes
Reserve the Skinny Drip, ask about peptide strips, or add this months injection and additive to your visit
About 78% were female, 72% White, and 90% non-Hispanic, demographics researchers say may limit how broadly findings apply elsewhere
In 2017, the Food and Drug Administration approved a new iteration, Ozempic (semaglutide), as a T2D treatment